These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12916913)

  • 1. Studies in formulation and pharmacotechnical evaluation of controlled release transdermal delivery system of bupropion.
    Gondaliya D; Pundarikakshudu K
    AAPS PharmSciTech; 2003; 4(1):E3. PubMed ID: 12916913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumatriptan succinate transdermal delivery systems for the treatment of migraine.
    Balaguer-Fernández C; Femenía-Font A; Del Rio-Sancho S; Merino V; López-Castellano A
    J Pharm Sci; 2008 Jun; 97(6):2102-9. PubMed ID: 17854062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel biomaterial for transdermal application: in vitro and in vivo characterization.
    Mundada AS; Avari JG
    Drug Deliv; 2011 Aug; 18(6):424-31. PubMed ID: 21554152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splitting bupropion extended-release tablets.
    Cochren BE
    Am J Health Syst Pharm; 1999 Mar; 56(6):575. PubMed ID: 10192696
    [No Abstract]   [Full Text] [Related]  

  • 7. Acrylic resins as rate-controlling membranes in novel formulation of a nine-day 17beta-estradiol transdermal delivery system: in vitro and release modifier effect evaluation.
    Rafiee-Tehrani M; Safaii-Nikui N; Peteriet H; Beckert T
    Drug Dev Ind Pharm; 2001 May; 27(5):431-7. PubMed ID: 11448050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eudragit matrices for sustained release of ketorolac tromethamine: formulation and kinetics of release.
    Ruckmani K; Muneera MS; Vijaya R
    Boll Chim Farm; 2000; 139(5):205-8. PubMed ID: 11213438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion sustained release: side effect profile.
    Settle EC
    J Clin Psychiatry; 1998; 59 Suppl 4():32-6. PubMed ID: 9554319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs acting as plasticizers in polymeric systems: a quantitative treatment.
    Siepmann F; Le Brun V; Siepmann J
    J Control Release; 2006 Oct; 115(3):298-306. PubMed ID: 17045358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of limonene-based transdermal therapeutic system of nicorandil in healthy human volunteers.
    Krishnaiah YS; Chandrasekhar DV; Rama B; Jayaram B; Satyanarayana V; Al-Saidan SM
    Skin Pharmacol Physiol; 2005; 18(6):263-72. PubMed ID: 16113596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
    Dave VS; Fahmy RM; Bensley D; Hoag SW
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and evaluation of monolithic matrix polymer films for transdermal delivery of nitrendipine.
    Mittal A; Sara UV; Ali A
    Acta Pharm; 2009 Dec; 59(4):383-93. PubMed ID: 19919928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion sustained release: a therapeutic overview.
    Davidson JR; Connor KM
    J Clin Psychiatry; 1998; 59 Suppl 4():25-31. PubMed ID: 9554318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delirium associated with concomitant use of low-dose bupropion sustained release and fluoxetine.
    Chan CH; Liu HC; Huang MC
    J Clin Psychopharmacol; 2006 Dec; 26(6):677-9. PubMed ID: 17110836
    [No Abstract]   [Full Text] [Related]  

  • 19. Bupropion extended-release for depressive disorders.
    Jefferson JW
    Expert Rev Neurother; 2008 May; 8(5):715-22. PubMed ID: 18457528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
    Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
    J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.